NASDAQ$LIDR
AEye Inc · Q3 2025 earnings
Q3 2025 earnings ·
Briefing
LIDR reported Q3 2025, a net loss of $15M.
For Q3 2025, LIDR reported a net loss of $15M. Management discusses operating trends, liquidity, and strategic priorities as disclosed in the quarterly filing.
- Net loss $15M.
- LIDR updated clinical, capital, or portfolio priorities in the filing.
- LIDR updated clinical, capital, or portfolio priorities in the filing.
Headline financials
Revenue & EPS history
AEye Inc · Revenue · Quarterly
$50K
Forward guidance
Management discusses LIDR's outlook, capital deployment, and key risks as disclosed in the earnings materials and periodic report.
Tailwinds
- LIDR cited progress on strategic priorities in the quarterly filing.
- Liquidity and balance sheet support continued operations and investment.
Headwinds
- GAAP profitability remained under pressure in the reported quarter.
- Macro, competitive, and regulatory factors may affect near-term results.
- R&D, credit, or project timing can create quarter-to-quarter volatility.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 14 quarterly earnings reports · overlaid with Q3 2025
-0.4%
Avg return
Earnings day
-1.1%
Avg return
5 days after
-9.9%
Avg return
30 days after
47%
7 / 15 earnings
Positive
+18.1%
Q4 2025
Best reaction
-15.1%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -15.1% | -26.9% | -34.7% | |
| Q4 2025 | +18.1% | +44.5% | +14.2% | |
| Q3 2025 | +3.4% | +6.9% | +13.8% | |
| Q2 2025 | -1.4% | -3.9% | -1.1% | |
| Q1 2025 | +8.0% | +22.1% | +36.7% | |
| Q3 2024 | -5.3% | -15.8% | -1.3% | |
| Q2 2024 | -3.2% | -12.0% | -13.6% | |
| Q1 2024 | -1.2% | -2.0% | -7.6% | |
| Q3 2023 | -5.6% | -5.1% | -35.0% | |
| Q2 2023 | -13.3% | -33.3% | -45.6% | |
| Q1 2023 | +2.5% | -1.5% | -7.4% | |
| Q3 2022 | +3.3% | +26.3% | +23.0% | |
| Q2 2022 | +0.4% | -22.0% | -42.8% | |
| Q1 2022 | +14.4% | +26.3% | -30.2% | |
| Q3 2021 | -11.2% | -20.7% | -17.0% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro